Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
No Image Available

Tenofovir Alafenamide Fumarate API Suppliers & Bulk Manufacturers

Available Forms: API (drug substance)

Available Strengths: USP grade or in-house specification

Reference Brands: Descovy, Vemlidy, Odefsey, Genvoya, Biktarvy

Category: Active Pharmaceutical Ingredient

Tenofovir alafenamide fumarate is a nucleotide reverse transcriptase inhibitor prodrug used in HIV and hepatitis B medicines. It is sourced by formulators, CDMOs and R&D teams.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Tenofovir Alafenamide Fumarate API? List it or send an offer →

Product Description:

Tenofovir alafenamide is a phosphonamidate prodrug of tenofovir, a nucleotide reverse transcriptase inhibitor; it is converted to the active form mainly inside cells, giving high levels there with less tenofovir in the blood than the older disoproxil prodrug. It is approved on its own for chronic hepatitis B in adults and in children aged 6 and older weighing at least 25 kg with compensated liver disease, and in combination tablets for the treatment of HIV-1 infection and, for one combination, HIV pre-exposure prophylaxis (reference brands: Vemlidy, Descovy, Odefsey, Genvoya, Biktarvy).

Specification at a glance

Traded formHemifumarate (2:1 tenofovir alafenamide to fumaric acid); white to off-white or tan powder, about 4.7 mg/mL soluble in water at 20 °C
CAS number1392275-56-7 (hemifumarate)
Molecular formulaC21H29N6O5P·½C4H4O4
Molecular weight534.50 g/mol (per tenofovir alafenamide unit); 476.5 g/mol (free base)
PharmacopoeiaNot verified. USP's April 2024 priority list names tenofovir alafenamide (fumarate) tablet monographs as new monographs to develop; a drug substance monograph in USP, Ph. Eur., JP, BP or IP could not be confirmed. Treat as an in-house specification unless the supplier cites a current compendial monograph.

Regulatory files and timing

The FDA list of Drug Master Files (third quarter 2026) shows 26 active Type II API DMFs for this molecule. There is a fair choice of sources, so compare documents and impurity profiles, not just price. For Europe, ask whether the supplier holds a CEP or an EU ASMF and, for imports into the EU, a written confirmation.

Generic or biosimilar entry. United States: Patent expiry; entry not confirmed (2031). European Union: Patent expiry; entry not confirmed (2027).

Handling and quality points

Tenofovir alafenamide has a stereogenic phosphorus atom, and the approved substance is a single diastereomer, so the specification must limit the other diastereomer and related isomers. The phosphonamidate and ester groups are prone to hydrolysis, so ask for water content limits, stability data and packaging with moisture protection. Confirm that the supplier offers the hemifumarate used in the reference products rather than another salt or co-crystal form.

Send an API enquiry All specialty APIs

Brand names are trademarks of their respective owners and identify the reference medicine only. Information is general and was checked in October 2026; confirm specifications and filings with the supplier before purchase.

Tenofovir Alafenamide Fumarate API — third party manufacturing & bulk supply

Tenofovir Alafenamide Fumarate API is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Tenofovir Alafenamide Fumarate API is supplied as API (drug substance) — a dosage form priced by order value, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Tenofovir Alafenamide Fumarate API listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Tenofovir Alafenamide Fumarate API →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

A GMP certificate, certificate of analysis and specification come first, with a US DMF letter of access and an EU ASMF or CEP where available for filings. Buyers also ask for diastereomeric purity data, a nitrosamine risk assessment and stability results that show control of hydrolysis products. For prequalification or tender supply, check what additional dossier format the programme requires.

The US labels describe the hemifumarate, with two molecules of tenofovir alafenamide per molecule of fumaric acid, and strengths are expressed as tenofovir alafenamide. Other salt and solid forms have been described in patents, so check the form, its stability and the patent position before committing to a source.

Yes. PharmaTradz connects licensed manufacturers, CDMOs and research teams with GMP-compliant producers of tenofovir alafenamide fumarate, after a first review of their documents. Your details stay private until both sides agree to proceed.

Related Products

Axitinib API

Strength:
USP grade or in-house specification

Form: API (drug substance)

Reference Brands: Inlyta

View Details
Ruxolitinib Phosphate API

Strength:
USP grade or in-house specification

Form: API (drug substance)

Reference Brands: Jakafi, Jakavi

View Details
Benralizumab Drug Substance

Strength:
Supplied to an in-house or pharmacopoeial specification

Form: Drug substance (bulk)

Reference Brands: Fasenra

View Details
Exatecan API

Strength:
Supplied to an in-house or pharmacopoeial specification

Form: API (drug substance)

Reference Brands: Enhertu, Datroway

View Details
Calicheamicin API (ADC Payload)

Strength:
Supplied to an in-house or pharmacopoeial specification

Form: API (drug substance)

Reference Brands: Mylotarg, Besponsa

View Details
Alectinib Hydrochloride API

Strength:
Supplied to an in-house or pharmacopoeial specification

Form: API (drug substance)

Reference Brands: Alecensa

View Details
Cabazitaxel API

Strength:
Supplied to an in-house or pharmacopoeial specification

Form: API (drug substance)

Reference Brands: Jevtana

View Details
Blinatumomab Drug Substance

Strength:
Supplied to an in-house or pharmacopoeial specification

Form: Drug substance (bulk)

Reference Brands: Blincyto

View Details
Enquire Now

Usually answered within 48 hours | GMP documents shared before you commit

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us